SAPK pathways and p53 cooperatively regulate PLK4 activity and centrosome integrity under stress

Nature Communications

Volumn 4, Issue , 2013, Pages

  Nakamura, Takanori ^a,b   Saito, Haruo ^a   Takekawa, Mutsuhiro ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

POLO LIKE KINASE; POLO LIKE KINASE 4; PROTEIN P53; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE KINASE KINASE; UNCLASSIFIED DRUG;

BIOCHEMISTRY; CANCER; CELL ORGANELLE; ENZYME ACTIVITY; GENE EXPRESSION; MUTATION; PROTEIN; TUMOR;

ARTICLE; CANCER CELL; CELL STRESS; CENTROSOME; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; GENE AMPLIFICATION; GENOTOXICITY; HUMAN; HUMAN CELL; PROTEIN EXPRESSION;

ANEUPLOIDY; ANIMALS; APOPTOSIS; CELL SURVIVAL; CENTROSOME; CYTOPLASM; DOWN-REGULATION; ENZYME ACTIVATION; FIBROBLASTS; G2 PHASE; HELA CELLS; HUMANS; IMMUNOPRECIPITATION; MAP KINASE KINASE 4; MAP KINASE SIGNALING SYSTEM; MICE; MITOSIS; MODELS, BIOLOGICAL; OSMOTIC PRESSURE; PHOSPHORYLATION; PHOSPHOTHREONINE; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; STRESS, PHYSIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84877732723     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms2752     Document Type: Article

References (60)

1. Nigg, E. A. & Stearns, T. The centrosome cycle: Centriole biogenesis, duplication and inherent asymmetries. Nat. Cell Biol. 13, 1154-1160 (2011).
2. Bornens, M. The centrosome in cells and organisms. Science 335, 422-426 (2012).
3. Thompson, S. L., Bakhoum, S. F. & Compton, D. A. Mechanisms of chromosomal instability. Curr. Biol. 20, R285-R295 (2010).
4. Ganem, N. J., Godinho, S. A. & Pellman, D. A mechanism linking extra centrosomes to chromosomal instability. Nature 460, 278-282 (2009).
5. Schvartzman, J. M., Sotillo, R. & Benezra, R. Mitotic chromosomal instability and cancer: mouse modelling of the human disease. Nat. Rev. Cancer. 10, 102-115 (2010).
6. Janssen, A., van der Burg, M., Szuhai, K., Kops, G. J. & Medema, R. H. Chromosome segregation errors as a cause of DNA damage and structural chromosome aberrations. Science 333, 1895-1898 (2011).
7. Zyss, D. & Gergely, F. Centrosome function in cancer: guilty or innocent? Trends Cell. Biol. 19, 334-346 (2009).
8. Chan, J. Y. A clinical overview of centrosome amplification in human cancers. Int. J. Biol. Sci. 7, 1122-1144 (2011).
9. Inanc, B., Dodson, H. & Morrison, C. G. A centrosome-autonomous signal that involves centriole disengagement permits centrosome duplication in G2 phase after DNA damage. Mol. Biol. Cell 21, 3866-3877 (2010).
10. Brun, E. et al. Oxidative stress induces mainly human centrin 2 polymerisation. Int. J. Radiat. Biol. 86, 657-668 (2010).
11. Gupta, R. K. & Srinivas, U. K. Heat shock induces chromosomal instability in near-tetraploid embryonal carcinoma cells. Cancer Biol. Ther. 7, 1471-1480 (2008).
12. Archambault, V. & Glover, D. M. Polo-like kinases: conservation and divergence in their functions and regulation. Nat. Rev. Mol. Cell Biol. 10, 265-275 (2009).
13. Bettencourt-Dias, M. et al. SAK/PLK4 is required for centriole duplication and flagella development. Curr. Biol. 15, 2199-2207 (2005). (Pubitemid 41790613)
14. Habedanck, R., Stierhof, Y. D., Wilkinson, C. J. & Nigg, E. A. The Polo kinase Plk4 functions in centriole duplication. Nat. Cell Biol. 7, 1140-1146 (2005).
15. Macmillan, J. C., Hudson, J. W., Bull, S., Dennis, J. W. & Swallow, C. J. Comparative expression of the mitotic regulators SAK and PLK in colorectal cancer. Ann. Surg. Oncol. 8, 729-740 (2001). (Pubitemid 32952489)
16. Rosario, C. O. et al. Plk4 is required for cytokinesis and maintenance of chromosomal stability. Proc. Natl Acad. Sci. USA 107, 6888-6893 (2010).
17. Ko, M. A. et al. Plk4 haploinsufficiency causes mitotic infidelity and carcinogenesis. Nat. Genet. 37, 883-888 (2005). (Pubitemid 41077116)
18. Basto, R. et al. Centrosome amplification can initiate tumorigenesis in flies. Cell 133, 1032-1042 (2008). (Pubitemid 351787756)
19. Castellanos, E., Dominguez, P. & Gonzalez, C. Centrosome dysfunction in Drosophila neural stem cells causes tumors that are not due to genome instability. Curr. Biol. 18, 1209-1214 (2008).
20. Swallow, C. J., Ko, M. A., Siddiqui, N. U., Hudson, J. W. & Dennis, J. W. Sak/Plk4 and mitotic fidelity. Oncogene 24, 306-312 (2005). (Pubitemid 40188612)
21. Morettin, A., Ward, A., Nantais, J. & Hudson, J. W. Gene expression patterns in heterozygous Plk4 murine embryonic fibroblasts. BMC Genomics 10, 319 (2009).
22. Vousden, K. H. & Lane, D. P. p53 in health and disease. Nat. Rev. Mol. Cell Biol. 8, 275-283 (2007). (Pubitemid 46474662)
23. Kruse, J. P. & Gu, W. Modes of p53 regulation. Cell 137, 609-622 (2009).
24. Avruch, J. MAP kinase pathways: the first twenty years. Biochim. Biophys. Acta 1773, 1150-1160 (2007). (Pubitemid 47125973)
25. Wagner, E. F. & Nebreda, A. R. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat. Rev. Cancer 9, 537-549 (2009).
26. Brosh, R. & Rotter, V. When mutants gain new powers: news from the mutant p53 field. Nat. Rev. Cancer 9, 701-713 (2009).
27. Greenman, C. et al. Patterns of somatic mutation in human cancer genomes. Nature 446, 153-158 (2007). (Pubitemid 46398669)
28. Whitmarsh, A. J. & Davis, R. J. Role of mitogen-activated protein kinase kinase 4 in cancer. Oncogene 26, 3172-3184 (2007). (Pubitemid 46763013)
29. Haeusgen, W., Herdegen, T. & Waetzig, V. The bottleneck of JNK signaling: molecular and functional characteristics of MKK4 and MKK7. Eur. J. Cell Biol. 90, 536-544 (2011).
30. Takekawa, M., Posas, F. & Saito, H. A human homolog of the yeast Ssk2/Ssk22 MAP kinase kinase kinases, MTK1, mediates stress-induced activation of the p38 and JNK pathways. EMBO J. 16, 4973-4982 (1997). (Pubitemid 27348406)
31. Gerwins, P., Blank, J. L. & Johnson, G. L. Cloning of a novel mitogen-activated protein kinase kinase kinase, MEKK4, that selectively regulates the c-Jun amino terminal kinase pathway. J. Biol. Chem. 272, 8288-8295 (1997). (Pubitemid 27147785)
32. Miyake, Z., Takekawa, M., Ge, Q. & Saito, H. Activation of MTK1/MEKK4 by GADD45 through induced N-C dissociation and dimerization-mediated trans autophosphorylation of the MTK1 kinase domain. Mol. Cell Biol. 27, 2765-2776 (2007). (Pubitemid 46581364)
33. Huangfu, W. C., Omori, E., Akira, S., Matsumoto, K. & Ninomiya-Tsuji, J. Osmotic stress activates the TAK1-JNK pathway while blocking TAK1-mediated NF-kB activation: TAO2 regulates TAK1 pathways. J. Biol. Chem. 281, 28802-28810 (2006). (Pubitemid 44507023)
34. Sato, S. et al. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat. Immunol. 6, 1087-1095 (2005). (Pubitemid 41541786)
35. Ninomiya-Tsuji, J. et al. A resorcylic acid lactone, 5Z-7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase. J. Biol. Chem. 278, 18485-18490 (2003). (Pubitemid 36799472)
36. Cizmecioglu, O. et al. Cep152 acts as a scaffold for recruitment of Plk4 and CPAP to the centrosome. J. Cell. Biol. 191, 731-739 (2010).
37. Soderberg, O. et al. Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat. Methods 3, 995-1000 (2006). (Pubitemid 44782698)
38. Li, J. et al. SAK, a new polo-like kinase, is transcriptionally repressed by p53 and induces apoptosis upon RNAi silencing. Neoplasia 7, 312-323 (2005). (Pubitemid 40664220)
39. Hers, I., Vincent, E. E. & Tavare, J. M. Akt signalling in health and disease. Cell Signal 23, 1515-1527 (2011).
40. Brenner, D. & Mak, T. W. Mitochondrial cell death effectors. Curr. Opin. Cell Biol. 21, 871-877 (2009).
41. Ventura, J. J. et al. Chemical genetic analysis of the time course of signal transduction by JNK. Mol. Cell 21, 701-710 (2006).
42. Arimoto, K., Fukuda, H., Imajoh-Ohmi, S., Saito, H. & Takekawa, M. Formation of stress granules inhibits apoptosis by suppressing stress-responsive MAPK pathways. Nat. Cell Biol. 10, 1324-1332 (2008).
43. Holland, A. J., Lan, W., Niessen, S., Hoover, H. & Cleveland, D. W. Polo-like kinase 4 kinase activity limits centrosome overduplication by autoregulating its own stability. J. Cell Biol. 188, 191-198 (2010).
44. Rodrigues-Martins, A., Riparbelli, M., Callaini, G., Glover, D. M. & Bettencourt-Dias, M. Revisiting the role of the mother centriole in centriole biogenesis. Science 316, 1046-1050 (2007). (Pubitemid 46799494)
45. Rogers, G. C., Rusan, N. M., Roberts, D. M., Peifer, M. & Rogers, S. L. The SCF Slimb ubiquitin ligase regulates Plk4/Sak levels to block centriole reduplication. J. Cell Biol. 184, 225-239 (2009).
46. Diskin, R., Askari, N., Capone, R., Engelberg, D. & Livnah, O. Active mutants of the human p38a mitogen-activated protein kinase. J. Biol. Chem. 279, 47040-47049 (2004). (Pubitemid 39518359)
47. Brancho, D. et al. Mechanism of p38 MAP kinase activation in vivo. Genes Dev. 17, 1969-1978 (2003). (Pubitemid 36999324)
48. Ahn, Y. H. et al. Map2k4 functions as a tumor suppressor in lung adenocarcinoma and inhibits tumor cell invasion by decreasing peroxisome proliferator-activated receptor g2 expression. Mol. Cell Biol. 31, 4270-4285 (2011).
49. Kan, Z. et al. Diverse somatic mutation patterns and pathway alterations in human cancers. Nature 466, 869-873 (2010).
50. Kiyono, T. et al. Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. Proc. Natl Acad. Sci. USA 94, 11612-11616 (1997). (Pubitemid 27451047)
51. Sillibourne, J. E. et al. Autophosphorylation of polo-like kinase 4 and its role in centriole duplication. Mol. Biol. Cell 21, 547-561 (2010).
52. Bozulic, L. & Hemmings, B. A. PIKKing on PKB: regulation of PKB activity by phosphorylation. Curr. Opin. Cell Biol. 21, 256-261 (2009).
53. MacCorkle-Chosnek, R. A., VanHooser, A., Goodrich, D. W., Brinkley, B. R. & Tan, T. H. Cell cycle regulation of c-Jun N-terminal kinase activity at the centrosomes. Biochem. Biophys. Res. Commun. 289, 173-180 (2001). (Pubitemid 33108811)
54. Cha, H., Wang, X., Li, H. & Fornace, Jr. A. J. A functional role for p38 MAPK in modulating mitotic transit in the absence of stress. J. Biol. Chem. 282, 22984-22992 (2007). (Pubitemid 47267360)
55. Tang, J., Yang, X. & Liu, X. Phosphorylation of Plk1 at Ser326 regulates its functions during mitotic progression. Oncogene 27, 6635-6645 (2008).
56. Huang, X. et al. JNK2 participates in spindle assembly during mouse oocyte meiotic maturation. Microsc. Microanal. 17, 197-205 (2011).
57. Lee, Y. J. et al. HSF1 as a mitotic regulator: phosphorylation of HSF1 by Plk1 is essential for mitotic progression. Cancer Res. 68, 7550-7560 (2008).
58. Boutros, R. et al. CDC25B associates with a centrin 2-containing complex and is involved in maintaining centrosome integrity. Biol. Cell 103, 55-68 (2011).
59. Bettencourt-Dias, M., Hildebrandt, F., Pellman, D., Woods, G. & Godinho, S. A. Centrosomes and cilia in human disease. Trends Genet. 27, 307-315 (2011).
60. Takekawa, M., Tatebayashi, K. & Saito, H. Conserved docking site is essential for activation of mammalian MAP kinase kinases by specific MAP kinase kinase kinases. Mol. Cell 18, 295-306 (2005). (Pubitemid 41350535)